Call Us: 1.800.873.5297

By

New FDA Guidelines Focus on Emphasizing Risks

The FDA has posted new draft regulations on its website. While these guidelines aren’t binding, they will help improve approval process by avoiding problems with omitting or minimizing important risk factors and information. The FDA will take public comment for 90 days before issuing new guidelines. Now the guidelines suggest instead of generally stating “certain […]

By

Doe Run Company may lose control of the La Oroya smelter

Under Peruvian law, there is a procedure called “restructuring of assets”, by which creditors of a company can ask the Peruvian agency, INDECOPI (a self-governing body parallel to the judiciary but under the administrative arena) can request restructuring of the company and seek to be appointed to a board of creditors that will administer the […]

By

Symptoms of Liver Damage from Hydroxycut

The Food and Drug Administration (FDA) decided to issue a public health advisory about the danger of liver damage from Hydroxycut use after compiling a total of 23 reports of liver injury associated with Hydroxycut use, including one death from liver failure. According to a letter to the editor published in the April 14, 2009 […]

By

Cancer Drug Erases Fingerprints

A Singapore man undergoing treatment was detained by U.S. immigration officials after the drug he was taking caused his fingerprints to disappear. The man, identified as Mr. S, was eventually allowed to enter the United States after officials determined he did not pose a threat to security. According to Mr. S’s oncologist, Eng-Huat Tan of […]

By

New Black Box Warning for Type II Diabetes Medicines

Those suffering from Type II diabetes, beware. The FDA has recently announced that they are issuing a new Black Box warning on the Type II diabetes medicines, Actos and Avandia. Both of these drugs have been connected with an increased risk for heart attacks and heart-related deaths. Anyone who has taken Actos or Avandia could […]

By

FDA Urges stricter warnings for Tylenol

After only one month, the FDA has already re-visited the enhanced warnings about the risk of liver damage from acetaminophen, a pain killer medication, better known as Tylenol. On April 28, 2009, the FDA announced that manufacturers of many over-the-counter painkillers and fever reducers would be required to place new warnings on their products of […]

By

Medicinal Marijuana Bill passes Illinois Senate

The Illinois Senate passed Bill 1381 yesterday which would allow for the legalization of medicinal marijuana. The bill will now go to the House for a vote. In order for the bill to pass the Senate, it needed a yes vote from at least 30 senators. The bill passed with a 30-28 vote. The bill […]

By

Reports of Hepatotoxicity for Orlistat, the Active Ingredient for Xenical and Alli

On April 16, 2009, the Drug Safety Oversight Board briefly discussed orlistat and the potential risk of hepatotoxicity. Orlistat is the active ingredient in anti-obesity drugs such as the prescription drug Xenical and the over-the-counter drug Alli. Xenical is manufactured by Roche, which is headquartered in Nutley, N.J. Alli is manufactured GlaxoSmithKline, which is headquartered […]

By

Various Manufacturers Recall Bicycles

The U.S. Consumer Product Safety Commission (CPSC) has recently announced the recall of bicycles from a number of manufacturers, including Trek, Cannondale, and Norco. Appoximately 16,000 Trek bikes, 1,500 Cannondale bikes, and 3,600 Norco bikes are affected by the recall. The problem with the Trek and Cannondale bikes is that the suspension fork loses alignment, […]

By

Treadmill Tragedy: Mike Tyson’s Daughter Taken off Life Support

Mike Tyson’s 4-year-old daughter Exodus was taken off life support and pronounced dead on Tuesday. Exodus Tyson’s 7-year-old brother discovered her Monday hanging from a treadmill cable in the family’s home. “Somehow she was playing on this treadmill, and there’s a cord that hangs under the console, it’s kind of a loop,” police Sergeant Andy […]

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.